Whole-blood Point-of-Care Activated Partial Thromboplastin Time Ratio (APR) is not Accurate Enough to Monitor Heparin Therapy in Patients with Severe Respiratory Failure Secondary to SARS-Cov-2 Infection Supported with Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO)

Support with VV-ECMO requires anticoagulation with unfractionated heparin to prevent thrombotic complications. This must be monitored due to bleeding risk. A point-of-care (POC) method of testing aPTT and APR was evaluated for agreement with laboratory methods. In a prospective observational study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Aston, Daniel, Besser, Martin, Goddard, Ben, Maggs, Nicholas, Ahmed, Hassan, Falter, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806398/
https://www.ncbi.nlm.nih.gov/pubmed/36572963
http://dx.doi.org/10.1177/10760296221148162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806398/
https://www.ncbi.nlm.nih.gov/pubmed/36572963
http://dx.doi.org/10.1177/10760296221148162

Ejemplares similares